Clinical Trial

NMD Pharma adds new capabilities with several senior recruits to support its growing business and pipeline

NMD Pharma adds new capabilities with several senior recruits to support its growing business and pipeline Aarhus, Denmark, 11 July…

2 years ago

Telix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals

MELBOURNE, Australia, July 11, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today welcomes proposed changes…

2 years ago

Mission Hill Highlights Advanced Formulations for Modern Health Needs, Focusing on Women’s Health

Innovative Products and Comprehensive Education for Health-Conscious ConsumersCALIFORNIA CITY, CA / ACCESSWIRE / July 10, 2024 / Mission Hill Foods…

2 years ago

Clearsense Strengthens Leadership through Trio of C-Suite Veteran Hires

Healthcare's leading data enablement platform provider completes its executive leadership team with the addition of a new CTO, CFO/COO, and Chief…

2 years ago

WakenAI Launches BTwin AI Friends, The First Emotional Support Network Inspired by Clones of Your Loved and Not-So-Loved Ones

After more than a year of clinical trials, BTwin pioneers new era of accessible emotional wellness powered by mind simulation…

2 years ago

JanOne Announces Plan to Enhance Stockholder Value Through Strategic Realignment

-The board has approved a strategic review of the biotech assets and ALT5 Sigma being the core focus going forward-…

2 years ago

Formedics Establishes Digital Hub OncWeekly to Connect Healthcare Professionals and Brands With the Latest in Oncology

BASKING RIDGE, N.J., July 10, 2024 /PRNewswire/ -- Formedics, a healthcare media company with a dynamic healthcare professional (HCP) engagement and…

2 years ago

Oracle Advances Safety Case Management for Life Science Organizations

New Oracle Argus and Safety One Intake enhancements make it easier for pharmacovigilance teams to increase efficiency and address global…

2 years ago

Skyhawk Therapeutics Announces Positive Topline Results from Parts A and B of its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease, Reaching 72% Huntingtin mRNA Reduction

Skyhawk’s SKY-0515 demonstrated dose-dependent huntingtin (HTT) mRNA reduction in healthy volunteers, with 72% reduction at the highest dose tested in…

2 years ago